Fingerprint
Dive into the research topics of 'Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
Gary Berman, Robert Croop, David Kudrow, Philip Halverson, Meghan Lovegren, Alexandra C. Thiry, Charles M. Conway, Vladimir Coric, Richard B. Lipton
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations